Evidence map›Paper›PMID 26342044›Full record

Observational studyClinical journal of the American Society of Nephrology : CJASN2015

Serum Uric Acid and Risk of CKD in Type 2 Diabetes.

Salvatore De Cosmo, Francesca Viazzi, Antonio Pacilli, Carlo Giorda, Antonio Ceriello, Sandro Gentile, Giuseppina Russo, Maria C Rossi, Antonio Nicolucci, Pietro Guida and 4 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 5 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 5 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Efficacy and Safety of Allopurinol on Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Salvatore De CosmoDue to the number of contributing authors, the affiliations are provided in the Supplemental Material. sdecosm@tin.it.
Francesca ViazziDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Antonio PacilliDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Carlo GiordaDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Antonio CerielloDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Sandro GentileDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Giuseppina RussoDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Maria C RossiDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Antonio NicolucciDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Pietro GuidaDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Daniel FeigDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Richard J JohnsonDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Roberto PontremoliDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
AMD-Annals Study Group
Casa Sollievo della Sofferenza · IT

Funding

BLRD VA I01 BX002586
6 · The paper itself

Abstract

BACKGROUND AND

objectiveSerum uric acid may predict the onset and progression of kidney disease, but it is unclear whether uric acid is an independent risk factor for diabetic nephropathy. Our aim was to study the relationship between uric acid levels and the development of CKD components in patients with type 2 diabetes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Longitudinal study of a cohort of patients with type 2 diabetes from the database of the Italian Association of Clinical Diabetologists network. From a total of 62,830 patients attending the diabetes centers between January 1, 2004, and June 30, 2008, we considered those with baseline eGFR values ≥60 ml/min per 1.73 m2 and normal albumin excretion (n=20,142). Urinary albumin excretion, GFR, and serum uric acid were available in 13,964 patients. We assessed the association of serum uric acid quintiles with onset of CKD components by multinomial logistic regression model adjusting for potential confounders. We calculated the relative risk ratios (RRRs) for eGFR <60 ml/min per 1.73 m2, albuminuria, and their combination at 4 years.

resultsAt 4-year follow-up, 1109 (7.9%) patients developed GFR <60 ml/min per 1.73 m2 with normoalbuminuria, 1968 (14.1%) had albuminuria with eGFR ≥60 ml/min per 1.73 m2, and 286 (2.0%) had albuminuria with eGFR <60 ml/min per 1.73 m2. The incidence of eGFR <60 ml/min per 1.73 m2 increased in parallel with uric acid quintiles: Compared with the lowest quintile, RRRs were 1.46 (95% confidence interval [CI], 1.14 to 1.88; P=0.003), 1.44 (95% CI, 1.11 to 1.87; P=0.006), 1.95 (95% CI, 1.48 to 2.58; P<0.001), and 2.61 (95% CI, 1.98 to 3.42; P<0.001) for second, third, fourth, and fifth quintiles, respectively. Serum uric acid was significantly associated with albuminuria only in presence of eGFR <60 ml/min per 1.73 m2.

conclusionsMild hyperuricemia is strongly associated with the risk of CKD in patients with type 2 diabetes.

Indexed as

AgedDiabetes Mellitus, Type 2FemaleHumansLongitudinal StudiesMaleMiddle AgedRenal Insufficiency, ChronicRisk FactorsUric AcidUric Acidalbuminuriadiabetes mellitusglomerular filtration rate

Identifiers

PMID26342044
PMCPMC4633786
OpenAlexW2140645838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.